90-Day Cancer Readmission
Cross-source consensus on 90-Day Cancer Readmission from 1 sources and 4 claims.
1 sources · 4 claims
How it works
Risks & contraindications
Comparisons
Highlighted claims
- Readmission associations with migrant density were consistent between Swedish-born and Western migrants before the pandemic. — Neighbourhood migrant density and outcomes in hospitalised patients with cancer before and during the COVID-19 pandemic in Sweden: a register-based retrospective cohort study
- Non-Western migrants showed no significant readmission association with migrant density before the pandemic but did show one during it. — Neighbourhood migrant density and outcomes in hospitalised patients with cancer before and during the COVID-19 pandemic in Sweden: a register-based retrospective cohort study
- The pandemic period saw increased readmission associations across all three population groups, representing a notable shift for non-Western migrants. — Neighbourhood migrant density and outcomes in hospitalised patients with cancer before and during the COVID-19 pandemic in Sweden: a register-based retrospective cohort study
- Disrupted cancer appointments in high migrant density areas during COVID-19 reduced access to treatment and rehabilitation, increasing the need for readmission. — Neighbourhood migrant density and outcomes in hospitalised patients with cancer before and during the COVID-19 pandemic in Sweden: a register-based retrospective cohort study